Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy VolunteersMark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Breast Cancer Research and Treatment|January 9, 2024
The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancerIngrid V Bonilla Valente, Denise Garcia, Andrea Abbott, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Oncoimmunology|August 19, 2021
Modeling <i>ex vivo</i> tumor-infiltrating lymphocyte expansion from established solid malignanciesHannah M Knochelmann, Amalia M Rivera-Reyes, Megan M Wyatt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2005
Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinomaYan Yan, Semyon Rubinchik, Patricia M Watson, et al.
American Journal of Cancer Research|September 15, 2011
Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memoryC Marcela Díaz-Montero, Osama Naga, Abdel-Aziz A Zidan, et al.
The Journal of Biological Chemistry|April 12, 2019
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cellsParamita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
Pageof 19